Mayumi Kanno
Fukushima, 9601295, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Brain-Derived Major Glycoproteins Are Possible Biomarkers for Altered Metabolism of Cerebrospinal Fluid in Neurological Diseases.
Journal: International journal of molecular sciences
Published: December 28, 2022
High Correlation among Brain-Derived Major Protein Levels in Cerebrospinal Fluid: Implication for Amyloid-Beta and Tau Protein Changes in Alzheimer's Disease.
Journal: Metabolites
Published: March 09, 2022
Total transferrin in cerebrospinal fluid is a novel biomarker for spontaneous intracranial hypotension.
Journal: Fukushima journal of medical science
Published: August 10, 2021
Transferrin Biosynthesized in the Brain Is a Novel Biomarker for Alzheimer's Disease.
Journal: Metabolites
Published: August 08, 2021
Spontaneous intracranial hypotension is diagnosed by a combination of lipocalin-type prostaglandin D synthase and brain-type transferrin in cerebrospinal fluid.
Journal: Biochimica et biophysica acta. General subjects
Published: November 07, 2017
Biological role of site-specific O-glycosylation in cell adhesion activity and phosphorylation of osteopontin.
Journal: The Biochemical journal
Published: March 16, 2017
Osteopontin O-glycosylation contributes to its phosphorylation and cell-adhesion properties.
Journal: The Biochemical journal
Published: July 08, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026